Account
Insider Insights
27.06.2022
EURORDIS release joint statement on patient access

They came up with six proposals, split into three subgroups, aimed at addressing the key barriers to...

Read more
News
15.06.2022
PMA Insights: Week 24

We summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...

Read more
Insider Insights
25.05.2022
Access consortium recommended by NICE in draft gui

The Access Consortium is made up of regulatory authorities including the UK, Australia, Canada, Sing...

Read more
Insider Insights
24.05.2022
Preliminary analysis of reformed early access

The High Authority for Health (HAS) and National Agency for Drug Safety (ANSM) have published a prel...

Read more
Insider Insights
20.05.2022
Improving market access for new drugs

With respects to pricing and reimbursement, the societies reportedly call for the criteria that led ...

Read more
Insider Insights
18.05.2022
Access to new treatments could extend lives

The research looks at the benefits for 13 medicines across four treatment areas.

Read more
News
18.05.2022
PMA Insights: Week 20

We summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...

Read more
04.05.2022
PMA Insights: Week 18

A short, 60 seconds read that summarises 4 handpicked articles that are worth reading about: Regulat...

Read more
Articles
28.04.2022
Regulators are giving early access to medicines, b...

Introduction Early Access Programs (EAPs) help to give people with life threatening or seriously deb...

Read more
Articles
25.04.2022
What do France’s ATU reforms mean for manufa...

Introduction On 1 July 2021, France made changes to its long-standing Authorization for Temporary Us...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.